Key Regulatory Considerations for Moving Your Cell Therapy Research to the Clinic

Understanding US FDA Regulatory Responsibilities for Cell Therapy CompaniesПодробнее

Enterprise solutions for cell and gene therapy - CytivaПодробнее

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene TherapyПодробнее

Meeting Regulatory Requirements for Cell and Gene Therapy ManufacturingПодробнее

Developing HEAL Pain Strategic Research Priorities: Biomarkers and PredictorsПодробнее

Webinar: Clinical Trials - Moving Stem Cell based Therapies to the Clinic, IntroductionПодробнее

CRISPR ExplainedПодробнее

Regulatory considerations for Cell and Gene Therapies - Jim DeKloeПодробнее

A-Cell: Regulatory ConsiderationsПодробнее

Catapult Your Cell Therapy Research Into the Clinic: CAR NK Cells & TregsПодробнее

2022 WMIF | Regulatory Perspectives on GCT: Past Lessons, Current Challenges, Future DirectionsПодробнее

Considerations in Gene and Cell Therapy Manufacturing - James Brown - RB2016Подробнее

Investigational Drugs & Stem Cell Treatments: Legal and Ethical Considerations of Right to Try LawsПодробнее

Catapult Your Cell Therapy Research Into the Clinic: Beyond Immuno-OncologyПодробнее

CTS Essential 8 Medium: Transition your PSC research to the clinic with confidenceПодробнее

Navigating regulatory challenges for cell and gene therapy products in 2024 and beyondПодробнее

What is stem cell therapy?Подробнее

Transitioning to the clinic from proof of concept researchПодробнее

Overcoming Manufacturing Challenges for Gene-Enabled Cell TherapiesПодробнее